Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer continues recalls of menopause drug Duavee on faulty packaging concerns
Fierce Pharma
Tue, 06/9/20 - 10:59 am
Tags:
drug manufacturing, Duavee, Pfizer, product recalls, Duavive, UK
Is Moderna Really the Leader in the COVID-19 Vaccine Race?
Motley Fool
Mon, 06/8/20 - 10:35 am
Tags:
vaccines, COVID-19, Moderna Therapeutics, AstraZeneca, Pfizer, JNJ, BioNTech, Merck, Sanofi, GSK, Novavax, Inovio
New safety data expose potential weakness as Pfizer's abrocitinib takes on Dupixent in eczema
Endpoints
Thu, 06/4/20 - 11:15 am
Tags:
Pfizer, abrocitinib, Dupixent, clinical trials, eczema
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Motley Fool
Wed, 06/3/20 - 11:39 pm
Tags:
vaccines, Donald Trump, Operation Warp Speed, COVID-19, Moderna Therapeutics, JNJ, Merck, Pfizer, AstraZeneca, BioNTech
Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis
Fierce Biotech
Tue, 06/2/20 - 11:05 am
Tags:
Pfizer, funding, biotech, pandemic, COVID-19
Pfizer Shares Dipped Following Release of Phase III Palbociclib Study Data
BioSpace
Mon, 06/1/20 - 11:38 pm
Tags:
Pfizer, palbociclib, breast cancer
Pfizer's Ibrance misses shot at big new market with early breast cancer failure
Fierce Pharma
Sun, 05/31/20 - 11:55 pm
Tags:
Pfizer, Ibrance, ASCO 2020, clinical trials, HER2-negative breast cancer
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Thu, 05/28/20 - 11:08 pm
Tags:
Pfizer, Merck KGaA, Bavencio, ASCO 2020, bladder cancer, gestational trophoblastic tumors, clinical trials
With bucks from Pfizer added to their new round, Amplyx steers a tricky course through PhII and a global pandemic
Endpoints
Tue, 05/19/20 - 10:30 am
Tags:
Amplyx, Pfizer, Novartis
Safety questions linger as Pfizer preps Duchenne gene therapy for final test
BioPharma Dive
Fri, 05/15/20 - 10:20 am
Tags:
Pfizer, gene therapy, Duchenne Muscular Dystrophy, PF-06939926
ASCO: Pfizer, Astellas show Xtandi helps early prostate cancer patients live longer
Fierce Pharma
Thu, 05/14/20 - 10:15 am
Tags:
ASCO 2020, Pfizer, Astellas, Xtandi, castration-resistant prostate cancer
ASCO: Roche's Alecensa stays on top of Xalkori with long-term survival showing
Fierce Pharma
Wed, 05/13/20 - 10:33 pm
Tags:
Roche, ASCO 2020, Xalkori, Alecensa, Pfizer, ALK-positive non-small cell lung cancer
Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall
Fierce Biotech
Wed, 05/13/20 - 11:18 am
Tags:
Pfizer, COVID-19, vaccines, BioNTech, clinical trials
What's Behind Mylan's Mixed Q1 Results
Motley Fool
Mon, 05/11/20 - 11:38 pm
Tags:
Mylan, Pfizer, Upjohn, M&A, Viatris, earnings
Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine
Motley Fool
Sun, 05/10/20 - 09:20 pm
Tags:
Pfizer, vaccines, outsourcing, drug manufacturing, BioNTech, COVID-19, BNT162
Pfizer tags 3 U.S. manufacturing sites for possible COVID-19 vaccine launch
Fierce Pharma
Thu, 05/7/20 - 10:56 am
Tags:
Pfizer, vaccines, COVID-19, drug manufacturing
Pfizer Launches U.S. Human Trial Of Coronavirus Vaccine
Forbes
Tue, 05/5/20 - 01:03 pm
Tags:
Pfizer, BioNTech, clinical trials, vaccines, COVID-19
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
MedCity News
Mon, 05/4/20 - 10:37 pm
Tags:
COVID-19, pandemic, Gilead Sciences, Pfizer, Eli Lilly, JNJ, Merck, Amgen
The top pharma companies in social media
Fierce Pharma
Mon, 05/4/20 - 11:02 am
Tags:
social media, Boehringer Ingelheim, AbbVie, GSK, Pfizer, Novo Nordisk, Eli Lilly, Novartis
Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva
Endpoints
Thu, 04/30/20 - 10:42 am
Tags:
Pfizer, Lyme disease, vaccines, Valneva

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.